NCT02602470 - Preferences & Treatment Satisfaction Drivers in Rosacea Patients | Biotech Hunter

Enrollment

206

Participants

Timeline

Start Date

January 8, 2015

Primary Completion Date

March 10, 2016

Study Completion Date

March 10, 2016

Conditions

Rosacea

Interventions

DRUG

Azelaic Acid Gel including: Finacea (Azelaic Acid Gel 15%, BAY39-6251)

Azelaic Acid Gel 15%, Azelaic Acid Gel 15% w/Cleanser \& Moisturizing

DRUG

Azelaic Acid Cream

Azelaic Acid Cream 20%

DRUG

Metronidazole gel

Metronidazole Gel 1%, Metronidazole Gel 1% w/ Cleanser, Metronidazole Gel 0.75%, Metronidazole Gel 0.75% w/ Cleanser

DRUG

Metronidazole cream

Metronidazole Cream 1%, Metronidazole Cream 0.75%, Metronidazole Cream 0.75% w/ Cleanser

DRUG

Metronidazole Emulsion

Metronidazole Emulsion 0.75%

DRUG

Metronidazole Lotion

Metronidazole Lotion 0,75%

DRUG

Brimonidine Tartrate Gel

Brimonidine Tartrate Gel 0.33%

Trial Locations (1)

Boston